NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy

Michel M. van den Heuvel*, Marcel Verheij, Rogier Boshuizen, Jose Belderbos, Anne-Marie C. Dingemans, Dirk De Ruysscher, Julien Laurent, Robert Tighe, John Haanen, Sonia Quaratino

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

56 Citations (Web of Science)
Original languageEnglish
Article number32
JournalJournal of Translational Medicine
Volume13
DOIs
Publication statusPublished - 27 Jan 2015

Keywords

  • Lung cancer
  • NHS-IL2
  • Immunotherapy
  • Radiotherapy
  • Phase Ib

Cite this